Salveen Richter
Stock Analyst at Goldman Sachs
(3.34)
# 1,035
Out of 5,131 analysts
206
Total ratings
41.74%
Success rate
5.72%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $28.32 | -11.72% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.28 | -22.97% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $23.04 | +64.93% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $21.30 | -24.88% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $81.66 | -20.40% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $23.20 | -22.41% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $20.57 | +26.40% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $370.91 | +52.60% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $7.50 | +406.67% | 6 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $21.14 | -10.12% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $26.59 | -36.07% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $25.03 | +47.82% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $55.30 | -15.01% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $57.71 | +80.21% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $17.04 | +140.61% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $18.26 | -45.24% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $768.00 | +4.69% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $185.63 | +6.13% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $7.80 | +130.92% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $122.60 | -21.70% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $33.84 | +50.71% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $17.95 | +122.84% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $11.43 | +4.99% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $127.12 | -43.36% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $106.33 | -34.17% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $24.37 | +211.86% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $325.54 | +7.51% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $460.59 | +21.37% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $22.02 | -77.29% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.67 | +1,756.29% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $277.89 | -19.03% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.28 | +414.02% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $23.87 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.06 | +638.92% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.81 | +87.11% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.86 | -38.27% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.58 | +31.00% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $71.78 | -40.09% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.26 | -53.05% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $5.88 | +1,600.68% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $17.91 | +3,250.08% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $118.46 | -57.79% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $65.93 | -31.75% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $28.32
Upside: -11.72%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.28
Upside: -22.97%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $23.04
Upside: +64.93%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $21.30
Upside: -24.88%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $81.66
Upside: -20.40%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $23.20
Upside: -22.41%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $20.57
Upside: +26.40%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $370.91
Upside: +52.60%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $7.50
Upside: +406.67%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $21.14
Upside: -10.12%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $26.59
Upside: -36.07%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $25.03
Upside: +47.82%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $55.30
Upside: -15.01%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $57.71
Upside: +80.21%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $17.04
Upside: +140.61%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $18.26
Upside: -45.24%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $768.00
Upside: +4.69%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $185.63
Upside: +6.13%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.80
Upside: +130.92%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $122.60
Upside: -21.70%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $33.84
Upside: +50.71%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $17.95
Upside: +122.84%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $11.43
Upside: +4.99%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $127.12
Upside: -43.36%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $106.33
Upside: -34.17%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $24.37
Upside: +211.86%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $325.54
Upside: +7.51%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $460.59
Upside: +21.37%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $22.02
Upside: -77.29%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.67
Upside: +1,756.29%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $277.89
Upside: -19.03%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.28
Upside: +414.02%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $23.87
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.06
Upside: +638.92%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.81
Upside: +87.11%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.86
Upside: -38.27%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.58
Upside: +31.00%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $71.78
Upside: -40.09%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.26
Upside: -53.05%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $5.88
Upside: +1,600.68%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $17.91
Upside: +3,250.08%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $118.46
Upside: -57.79%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $65.93
Upside: -31.75%